CG Oncology (CGON) Competitors $27.74 +0.80 (+2.97%) Closing price 04:00 PM EasternExtended Trading$27.62 -0.12 (-0.43%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CGON vs. LEGN, TGTX, TLX, BPMC, SRPT, AXSM, NUVL, VRNA, GRFS, and KRYSShould you be buying CG Oncology stock or one of its competitors? The main competitors of CG Oncology include Legend Biotech (LEGN), TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Blueprint Medicines (BPMC), Sarepta Therapeutics (SRPT), Axsome Therapeutics (AXSM), Nuvalent (NUVL), Verona Pharma (VRNA), Grifols (GRFS), and Krystal Biotech (KRYS). These companies are all part of the "pharmaceutical products" industry. CG Oncology vs. Legend Biotech TG Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Blueprint Medicines Sarepta Therapeutics Axsome Therapeutics Nuvalent Verona Pharma Grifols Krystal Biotech Legend Biotech (NASDAQ:LEGN) and CG Oncology (NASDAQ:CGON) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, community ranking, analyst recommendations and institutional ownership. Does the MarketBeat Community prefer LEGN or CGON? Legend Biotech received 63 more outperform votes than CG Oncology when rated by MarketBeat users. However, 90.00% of users gave CG Oncology an outperform vote while only 72.58% of users gave Legend Biotech an outperform vote. CompanyUnderperformOutperformLegend BiotechOutperform Votes9072.58% Underperform Votes3427.42% CG OncologyOutperform Votes2790.00% Underperform Votes310.00% Does the media refer more to LEGN or CGON? In the previous week, CG Oncology had 20 more articles in the media than Legend Biotech. MarketBeat recorded 27 mentions for CG Oncology and 7 mentions for Legend Biotech. Legend Biotech's average media sentiment score of 1.25 beat CG Oncology's score of 0.47 indicating that Legend Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Legend Biotech 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CG Oncology 6 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Neutral Is LEGN or CGON more profitable? Legend Biotech has a net margin of -66.92% compared to CG Oncology's net margin of -10,642.98%. CG Oncology's return on equity of -18.97% beat Legend Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Legend Biotech-66.92% -29.69% -19.45% CG Oncology -10,642.98%-18.97%-15.36% Do insiders & institutionals believe in LEGN or CGON? 70.9% of Legend Biotech shares are owned by institutional investors. Comparatively, 26.6% of CG Oncology shares are owned by institutional investors. 0.0% of Legend Biotech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has preferable valuation & earnings, LEGN or CGON? CG Oncology has lower revenue, but higher earnings than Legend Biotech. Legend Biotech is trading at a lower price-to-earnings ratio than CG Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLegend Biotech$627.24M9.94-$518.25M-$0.48-70.75CG Oncology$1.14M1,856.24-$48.61M-$1.42-19.54 Which has more risk & volatility, LEGN or CGON? Legend Biotech has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500. Comparatively, CG Oncology has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500. Do analysts prefer LEGN or CGON? Legend Biotech currently has a consensus price target of $78.82, indicating a potential upside of 132.09%. CG Oncology has a consensus price target of $59.56, indicating a potential upside of 114.69%. Given Legend Biotech's higher probable upside, analysts plainly believe Legend Biotech is more favorable than CG Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Legend Biotech 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92CG Oncology 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryCG Oncology beats Legend Biotech on 10 of the 19 factors compared between the two stocks. Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGON vs. The Competition Export to ExcelMetricCG OncologyBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.11B$2.95B$5.47B$7.93BDividend YieldN/A1.89%5.11%4.22%P/E Ratio-19.5430.0722.5118.54Price / Sales1,856.24494.82397.62103.35Price / CashN/A168.6838.1834.62Price / Book-14.303.176.734.25Net Income-$48.61M-$72.35M$3.22B$248.18M7 Day Performance28.90%0.95%1.58%1.25%1 Month Performance25.80%8.28%4.05%3.76%1 Year Performance-31.71%-22.65%15.75%5.28% CG Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGONCG Oncology2.1128 of 5 stars$27.74+3.0%$59.56+114.7%-33.0%$2.11B$1.14M-19.5461Upcoming EarningsAnalyst ForecastNews CoverageLEGNLegend Biotech2.6421 of 5 stars$32.24-1.7%$79.00+145.0%-20.1%$5.92B$627.24M-33.941,070Positive NewsTGTXTG Therapeutics3.3177 of 5 stars$36.97-3.5%$40.67+10.0%+233.2%$5.81B$329.00M-369.66290Upcoming EarningsNews CoveragePositive NewsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.21-3.0%$22.00+35.7%N/A$5.48B$783.21M0.00N/AAnalyst RevisionNews CoverageBPMCBlueprint Medicines2.5642 of 5 stars$84.18-0.6%$124.95+48.4%-2.0%$5.38B$508.82M-77.94640Earnings ReportAnalyst ForecastNews CoveragePositive NewsSRPTSarepta Therapeutics4.7413 of 5 stars$55.23+2.7%$158.70+187.3%-50.7%$5.36B$1.90B44.18840AXSMAxsome Therapeutics4.8364 of 5 stars$103.00-1.4%$169.80+64.9%+52.2%$5.02B$385.69M-17.20380Upcoming EarningsAnalyst ForecastShort Interest ↓Positive NewsNUVLNuvalent1.887 of 5 stars$69.95-2.4%$115.50+65.1%+11.4%$5.01BN/A-20.1640Upcoming EarningsPositive NewsVRNAVerona Pharma2.9073 of 5 stars$60.07+2.0%$75.43+25.6%+366.5%$4.85B$42.28M-31.2930Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoveragePositive NewsGRFSGrifols3.8939 of 5 stars$7.01-1.0%N/A+8.1%$4.82B$7.21B5.9926,300KRYSKrystal Biotech4.9058 of 5 stars$161.91-4.0%$220.00+35.9%+10.9%$4.68B$290.52M54.15210Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoveragePositive News Related Companies and Tools Related Companies Legend Biotech Competitors TG Therapeutics Competitors Telix Pharmaceuticals Limited American Depositary Shares Competitors Blueprint Medicines Competitors Sarepta Therapeutics Competitors Axsome Therapeutics Competitors Nuvalent Competitors Verona Pharma Competitors Grifols Competitors Krystal Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGON) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CGON Stock Free CGON Stock Alerts